Posts Tagged: CTC

BreastCancer_700x233

New webinar: HER2, CTCs and tumor stemness

About 20–30% of breast cancer tumors overexpress the oncogene human epidermal growth factor receptor 2 (HER2), which – if not treated with a targeted anti-HER2 regimen – leads to higher aggressiveness and mortality. Recently, a number of studies have shown that expression of HER2 in circulating tumor cells (CTCs) varies compared to expression in primary tumors…. Read article →


SlideShare_LabBench_LiquidBiopsy_700x233

Liquid biopsy resources on SlideShare

QIAGEN offers a complete, efficient and streamlined workflow to empower your liquid biopsy research. We have added our newest webinar presentations and videos covering circulating cell-free DNA, circulating tumor cells and exosomes to SlideShare. Whether you want to learn how to collect and stabilize blood samples, discover a complete and efficient workflow for ccfDNA analysis,… Read article →


BreastCancer_Metastasis_700x233

Towards personalized cancer care: liquid biopsy for monitoring primary breast cancer

Breast cancer is the most common cancer in women, accounting for 23% of all cancer diagnoses (1). At the time of diagnosis, a majority of patients (>90%) will have localized disease, which is typically treated with surgery, radiation and therapeutic agents. Localized disease is associated with improved five-year survival rates, relative to more advanced cancers… Read article →